The RCVS has extended the deadline for nominations for the RCVS Queen's Medal to 31 January, to allow time for the nominations paperwork to be completed on return from the Christmas and New Year break.
RCVS CEO Nick Stace said: "We received more enquiries about the Queen's Medal over the Christmas period but appreciated that people might welcome a little extra time in the new year to complete and submit their nominations. We're certainly keen to allow anyone who wishes to make a nomination for this very special award the chance to do so."
The Queen's Medal, launched at the House of Lords last November, is a new Honour that will be awarded to a veterinary surgeon for a lifetime of outstanding contributions to the profession and who has dedicated their career to working above and beyond the call of duty in the fields of veterinary medicine or science, or related areas.
It is the most prestigious Honour that the RCVS can bestow, and will be awarded at RCVS Day in London in July.
Full details about the nominations process are available on the RCVS website (www.rcvs.org.uk/Queensmedal). Nominations should be received by the RCVS no later than 5pm on Friday, 31 January 2014.
Veterinary Practices are being urged to come forward and enter their PR campaigns for this year's Veterinary Marketing Association (VMA) PR Award for 2013.
The aim of the PR Award is to recognise the value that media and public relations can add to the marketing mix, says award sponsor, Jane Manning of Splash Communications.
Jane said: "PR comes in many forms, including social media, but you don't always need big budgets to deliver the most effective campaigns. Regional press, newsletters and radio or local TV broadcasts are all ways that vets can promote their business or specific initiatives. We know that many practices are highly active across many of these mediums, helping to promote the practice or specific initiatives to a local audience."
She added: "The award is given to the company, organisation or veterinary practice that has delivered the most innovative and effective PR campaign during the previous year, as judged by a panel of industry professionals. This can be a single 'one-off' event or article, or a sustained campaign over a given period".
The winner and two highly commended entries will be announced at the VMA Awards on Friday 14th March 2014, at The London Lancaster Hotel.
Deadline for entries is Friday 31st January 2014. Further information on the awards and ticket application forms are available at the VMA's website: www.vma.org.uk or by calling 0844 561 6157.
The Animal Health Trust is calling for all small animal practitioners to help with a prospective survey study on breed differences in clinical features in canine hyperadrenocorticism.
The Trust is asking vets that diagnose a case of spontaneous hyperadrenocorticism to complete an online questionnaire at bit.ly/aht-cushing.
The questionnaire should take 10 minutes to complete and all the information will be processed anonymously. Each questionnaire submitted has a chance to win a £100 Amazon voucher. On completing the survey, participants can ask to be notified of the results of this study when available.
Researchers say they hope this data will help veterinary surgeons in the diagnosis of canine hyperadrenocorticism, and ask that everyone helps spread the word about the study.
If you have any queries about this study, please contact michael.bennaim@aht.org.uk
Petplan has been voted Best Insurance Provider in the seventh annual Your Cat and Your Dog Product Awards.
This is the sixth consecutive year Your Cat and Your Dog readers have voted Petplan number one, in response to a survey completed by thousands of pet owners.
Isabella von Mesterhazy, Head of Marketing at Petplan said: "To be independently voted number one provider by pet owners means so much, particularly as this is the sixth time we have been awarded this honour.
"Petplan's Covered for Life policy is the original lifetime policy - we were the first insurer to offer this type of policy and cover. This, combined with over 36 years' experience in the pet insurance marketplace means Petplan truly understands what pet owners need and want from their pet insurance. We settle 97% of claims successfully and 90% of customers renew each year. Moreover, we paid out over £180 million in claims in 2013, the majority directly with the vet, which leaves owners able to concentrate on supporting their pet back to full health rather than worrying about vet bills."
Elanco has announced the results of a survey it conducted amongst European dermatology diplomates which found that nearly 90% of them consider Comfortis (spinosad) is the first choice of flea control for cats and dogs.
The research was conducted at the European Society of Veterinary Dermatology (ESVD) and European College of Veterinary Dermatology (ECVD) Congress 2013. 49 Dip ESVD holders from around Europe were asked:
Research has shown that dermatological cases account for approximately 20% of small animal consultations conducted by general practitioners1. According to Elanco, further industry investigations have found that skin diseases are two to three times more common than the next disease category, and dermatological problems are a common secondary reason for an examination.
Anna Jackson, national veterinary manager at Elanco Companion Animal Health, said: “Skin diseases are a huge part of a practicing vet’s workload and one which can prove challenging to effectively address. By creating a fast acting oral flea control product that can work alongside other topical dermatological treatments, we’re helping to alleviate the discomfort and consequences of flea allergy dermatitis, which is one of the most common causes of skin disease. It’s fantastic to receive such strong endorsements from some of the leading dermatologists in Europe and this underlines the benefits of using Comfortis for flea control.”
Reference
Boehringer Ingelheim Vetmedica has launched trial size Seraquin dispensing strips so clients can try a week's supply of the veterinary joint support supplement for cats and dogs.
Rob Lucy, brand manager for Seraquin, said: "With 9 out of 10 dogs and cats eating Seraquin as a treat, the new dispensing strips are a great way to enable pet owners to experience just how palatable it is."
Each pack of Seraquin dog dispensing strips contains 40 strips of 10 chewable tablets. Each pack of Seraquin cat and small dog dispensing strips contains 10 strips of 20 chewable tablets.
Boehringer says that for each pack of Seraquin dog dispensing strips purchased, veterinary practices will get one pack of Seraquin cat and small dog dispensing strips free. In addition, the company will make a £20 donation to Hounds for Heroes on behalf of each practice that orders Seraquin Dispensing Boxes. The donations will help to buy, train and support an assistance dog for an injured or disabled man or woman from the UK armed forces or civilian emergency services.
For further information, contact your Boehringer territory manager.
Royal Canin has announced the launch of two new veterinary diets designed to tackle obesity in cats and dogs.
'Satiety Small Dog' is for adult dogs with an ideal weight up to 10kg. 'Satiety Wet' has been developed for those dogs who prefer wet food, or who are used to eating a combination of wet and dry food.
Satiety Small Dog is available in 1.5kg, 3.5kg and 8kg bags and contains a blend of fibres that Royal Canin says increases the volume of stomach contents and promotes satiety. The company says the new diet also contains specific nutrients which contribute to maintaining good oral health, and a high protein content to help maintain muscle mass during the weight loss programme.
Satiety Small Dog is designed to improve digestive tolerance in smaller breeds, as it has a different blend of fibre and higher levels of butyrate than Satiety Canine, which is formulated for the needs of medium and larger dogs. The diet contains less dietary oxalate which Royal Canin claims is of benefit to smaller dogs that are at a greater risk of developing calcium oxalate uroliths.
The second new diet, Satiety Wet for Dogs, is available in 410g and 195g cans. The diet has a high protein content (14.1g per 100kcal), and is enriched with nutrients, minerals and vitamins. Royal Canin also highlights what it says is a particularly innovative feature: a high fibre content in a canned diet.
Ian Williams, Veterinary Scientific Support Manager at Royal Canin, said: "Almost 60% of dogs and 40% of cats in the UK and Ireland are overweight or obese. With obesity comes an increased risk of animals developing conditions affecting the upper respiratory tract, cardiopulmonary system, joints and urinary tract. In cats obesity is also a major risk factor for Type II diabetes mellitus. In essence, obesity can lead to a decreased life expectancy and a reduced quality of life.
"Royal Canin has a proven track record of developing innovative diets to help these pets and the latest additions to our range really will complement the existing choice for vets and their clients."
A new US colic study, published in Equine Veterinary Journal (EVJ), in partnership with the American Association of Equine Practitioners, has identified various risk factors, including delayed faecal output and increasing blood lactate, associated with post-anaesthetic colic.
The study Risk factors associated with gastrointestinal dysfunction in horses undergoing elective procedures under general anaesthesia was conducted by surgeons based at the College of Veterinary Medicine and Biomedical Sciences at Colorado State University, USA.
The authors say that the research should enable vets to implement preventative measures to help reduce incidences of colic in the future.
Gastrointestinal pain has been estimated to occur in 2.8-6% of horses following general anaesthesia for elective procedures, the most common cause being impaction of the large intestine or caecum.
The medical records of 416 horses undergoing general anaesthesia were collected over a two-year period and the potential risk factors were examined. 8.7% of horses were diagnosed with gastrointestinal dysfunction - higher than previous estimates probably because the study included horses requiring treatment for decreased faecal output whereas previous studies did not. Potential risk factors were assessed, including faecal output, which was decreased in 38.9% of cases, blood lactate, position during surgery, rectal temperature and breed of horse.
The results showed that Arabian horses, increasing blood lactate, right lateral recumbency, decreased rectal temperature post-procedure and delayed passage of faeces were significantly associated with an increased risk of gastrointestinal dysfunction.
Diana Hassel, who instigated the study, said: "These findings should help the clinician identify higher risk horses and be proactive about their management in the post-anaesthetic period.
"This may include pre-emptive nasogastric intubation and administration of mineral oil and/or water and electrolytes. Although core temperature control in horses is difficult to achieve in adult horses during surgery, further research into this field may prove beneficial."
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "This study brings obvious and immediate practical benefits for clinicians and the horses under their care. Rigorous monitoring of higher risk surgical cases should lead to a reduction in incidences of post-operative colic, making recovery procedures less difficult and outcomes more favourable."
A study published in Current Biology has demonstrated that there are remarkable similarities in the way that dog and human brains respond to sound, and that dog brains, like those of people, are also sensitive to acoustic emotional cues.
Lead by Attila Andics, researchers from MTA-ELTE Comparative Ethology Research Group in Hungary trained 11 dogs to lay motionless in an fMRI brain scanner. This made it possible to run the same neuroimaging experiment on both dog and human participants - something that had never been done before. They captured both dogs' and humans' brain activities while the subjects listened to nearly 200 dog and human sounds, ranging from whining or crying to playful barking or laughing.
The resultant scans showed that dog and human brains include voice areas in similar locations. Not surprisingly, the voice area of dogs responds more strongly to other dogs while that of humans responds more strongly to other humans.
The researchers also noted striking similarities in the ways the dog and human brains process emotionally loaded sounds. In both species, an area near the primary auditory cortex lit up more with happy sounds than unhappy ones. Andics says the researchers were most struck by the common response to emotion across species.
There were some differences, too: in dogs, 48% of all sound-sensitive brain regions respond more strongly to sounds other than voices. That's in contrast to humans, in which only 3% of sound-sensitive brain regions show greater response to nonvocal versus vocal sounds.
The researchers say that the findings suggest that voice areas evolved at least 100 million years ago, the age of the last common ancestor of humans and dogs. It also offers new insight into humans' unique connection with our best friends in the animal kingdom and helps to explain the behavioural and neural mechanisms that made this alliance so effective for tens of thousands of years.
Andics said: "This method offers a totally new way of investigating neural processing in dogs. At last we begin to understand how our best friend is looking at us and navigating in our social environment."
Photograph: Borbala Ferenczy. Dogs at the MR Research Centre (Budapest).
Organisers of The Vet Charity Challenge, which last year raised £50,000 for charity, have announced that the event will take place Saturday 27th September 2014 in Pewsey, near Marlborough, Wiltshire.
The event consists of teams of four walking/running, cycling and kayaking as well as some orienteering and mental and physical tasks.
Registration will open at the start of April. Organisers say that spaces are limited and in 2013 filled up very fast, so early booking is advisable.
The charities being supported in 2014 will be Hearing Dogs for Deaf People, SPANA and Cats Protection.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse and Vetoquinol and supported by the VMPA and Veterinary Practice magazine.
For more information visit www.vetcharitychallenge.co.uk.
Novartis Animal Health has launched 'The Wormer Decision Tree', an online tool to help veterinary surgeons in giving sheep farmers the most up-to-date advice about worming.
Lesley Stubbings, SCOPS representative and Independent Sheep Consultant said: “Choosing the right wormer group is hugely important and there remains much confusion especially when it comes to anthelmintic resistance.
“Worms, including resistant and multi-resistant species, are threatening the productivity of sheep farms. However with a well-thought-out worming strategy that uses both the new wormer groups, in association with existing wormers, it is possible to slow resistance.”
Results of the Farming Against Wormer Resistance (FAWR) campaign survey, conducted in 2013, revealed growing concern about wormer resistance among farmers - but confusion about the best course of action to take.
Fiona Anderson, Novartis Animal Health Veterinary Manager said: "This tool has been developed adhering to SCOPS principles and is designed to ensure a consistent responsible approach is used when prescribing anthelmintics.
"Available only to SQPs and vets, it will be a valuable tool to train new staff and use with farmers, to explain which of the five drench classes are appropriate for particular sheep groups at specific times of year."
The Novartis Wormer Decision Tree asks three key questions: the type of sheep being dosed, the purpose of the dose, and the farm's resistance status. It then produces a recommendation of the required active ingredient, along with more detailed information to support the recommendation. There is also a calculator which provides a dose rate and cost per dose based upon the recommendation.
To use the decision tree, you must first register on the Novartis Farm Animal Health website: www.farmanimalhealth.co.uk. Then head here: www.farmanimalhealth.co.uk/wormerdecisiontree
Dechra Veterinary Products has launched Anesketin, an anaesthetic licensed for cats, dogs and horses.
Anesketin contains ketamine 100mg/ml solution for injection and is indicated for induction of anaesthesia. In cats, it can also be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required.
Dechra Brand Manager Carol Morgan said: "Anesketin is a versatile product which can be used as a sole agent in cats or in combination with appropriate sedatives and analgesics in cats, dogs and horses for induction and maintenance of anaesthesia.
Anesketin is available in 10 ml vials. The withdrawal period for meat, offal and milk is one day and the product does not require any special storage conditions.
For further information, visit www.dechra.co.uk
The Animal Welfare Foundation (AWF) has produced a leaflet which guides pet owners through the euthanasia decision making process.
The leaflet 'Saying goodbye - the ultimate kindness' explains why euthanasia may be the most caring option, the choices owners have, the different ways euthanasia may be performed and what happens next. It also addresses the emotions owners may go through when deciding to put their pet down.
AWF Chairman Tiffany Hemming said: "As vets we often see pet owners struggle with letting their pet go. Guilt may be the strongest emotion owners feel when deciding to put their pet down. We wanted to guide owners through this difficult time in a sensitive way and encourage them to ask questions and work with the vet to help them come to terms with the end of their pet's life.
"While the leaflet is aimed at pet owners we hope vets find it a useful communication tool during this distressing time for their clients."
To see all AWF leaflets including 'Pre- and post-operative care', 'Pet travel', 'Pets and poisons', and 'What makes my pet happy' visit http://www.bva-awf.org.uk/pet-care-advice.
Practices can order batches of the leaflets for clients in return for a donation to AWF by contacting bva-awf@bva.co.uk.
Zoetis has announced the launch of Apoquel (oclacitinib maleate), a new treatment for pruritus associated with canine allergic dermatitis and the clinical manifestations of atopic dermatitis.
Uniquely, the new treatment inhibits the JAK enzyme, a protein that is integral to the signalling pathway of cytokines that are pro-inflammatory or have a role in allergic and itch response.
According to the company, pruritus affects about one in six dogs whose owners seek veterinary help, and about half of all itchy dogs will have an underlying allergic skin condition for which the new product would be indicated.
Zoetis says that because Apoquel targets the specific pathways of pruritus (itch) and inflammation, it is less likely to cause unwanted side effects than glucocorticoids and demonstrates anti-pruritic efficacy within four hours.
Pascal Prélaud, a dermatology specialist from Paris, who took part in the clinical development programme of Apoquel, said: "When a dog develops an itch related to an allergy, it can be life-disrupting for the dog and the entire family. I've learned firsthand the fundamental difference this treatment can make to a dog and its owners in stopping the itch, but without many of the side-effects that are common with steroids.
Zoetis reports that in clinical trials, Apoquel demonstrated a good safety profile and efficacy for the treatment of pruritus and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners within 24 hours of administration, and pruritus continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinarians were significantly improved after one week and continued to improve long term during the studies (four months).
Apoquel is a POM. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium- to long-term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Ceva Animal Health has launched Vectra 3D, a broad spectrum topical ectoparasiticide for dogs which is effective against fleas, ticks and flies.
Vectra 3D contains a formulation of a brand new active called dinotefuran, pyriproxyfen and permethrin.
According to the company, Vectra 3D provides a rapid flea kill within two hours for dogs on current treatment and complete protection against the major vectors: fleas, ticks, sand flies, mosquitoes and stable flies1. Additionally, because dinotefuran kills on contact, it is claimed to reduce the incidence of flea feeding1.
Vectra 3D is applied in a line from the base of the tail to the neck using a patented applicator with an elongated tip, designed to make it easy to apply the product through the hair directly onto the skin. The applicator is also designed to provide accurate dosing without making any mess, as nothing comes out until the tube is squeezed.
Ceva highlights that the number of people travelling with their pets has increased by 61% since 20122, and that Vectra 3D is the only topical ectoparasiticide that offers repellent action against sand flies for one month, together with protection against mosquitoes and stable flies.
Julia Wood, product manager at Ceva Animal Health said: "Vectra 3D is an innovative formulation which uses a unique, easy-to-administer applicator to provide complete protection against fleas, ticks and flies. And with spring nearly upon us, it's time to start talking to clients about flea treatments, such as Vectra 3D."
To support the launch of Vectra 3D, Ceva is hosting a series of CPD meetings at venues across the UK. Accounting for two hours CPD, the afternoon meetings will cover vector-borne diseases, the importance of ticks in the UK and product information on Vectra 3D. They will be presented by Ian Wright BVMS BSc MSc MRCVS and Richard Wall BSc MBA PhD FRES and take place at:
For further information, contact your Ceva Animal Health territory manager or email Ceva Animal Health on customerservicesuk@ceva.com.
Bayer Animal Health has announced the results of a survey1 which shows that despite 80% of dog owners being aware of lungworm (Angiostrongylus vasorum), 85% of dogs remain unprotected against the parasite.
The survey, which was carried out amongst 1,000 dog owners, also found that more than 5% had encountered lungworm in their own dogs. However, only 15% of owners treat their pet against parasites on a monthly basis, with the remainder admitting to missed routine lungworm worming treatments or not treating at all.
Bayer highlights evidence from the Royal Veterinary College2, which confirms the lungworm parasite has spread across the UK from its traditional habitat in the south of England and Wales, and is now widespread in Central England, also reaching northern regions and Scotland, with one in five vet practices nationwide reporting at least one case of the parasite. In another survey of 150 veterinary practices across the UK a total of 952 suspected cases were reported (157 laboratory confirmed), with 81 deaths thought to have been caused by the parasite3.
To encourage more pet owners to take action, Bayer will launch a consumer campaign called 'Act on Lungworm' in March. The campaign will include the world's first 24-hour radio station for dogs and their owners, 'Hound Waves', broadcasting live from Crufts on Friday 7th March. The event will also see the launch of a new television and advertising campaign from Bayer.
For veterinary professionals, the campaign launch will also include online videos detailing the 'ACT on Lungworm' veterinary support and showing the new television advertisement exclusively to vets before the national launch.
Caroline Braidwood, Group Product Manager at Bayer Animal Health said: "After launching the 2013 lungworm awareness campaign and providing owners with a social media platform, we quickly began to recognise the enthusiasm that exists to encourage action.
"We received feedback from owners who had tragically lost their pets to lungworm, and whilst we were pleased that we were helping to raise awareness, we became conscious that we needed to do more to prevent dogs from dying unnecessarily. Our 2014 campaign focus has come as a direct result of talking to these owners and providing individuals like Sandra Stevens with a platform to discuss their experiences in the hope that more owners will take action before it is too late."
'ACT on Lungworm' is part of Bayer Animal Health's wider 'It's a Jungle Out There' parasite protection initiative. Further information is available at www.facebook.com/jungleforpets
References
Novartis Animal Health has announced the launch of a campaign to improve awareness of and improve education about atopic dermatitis (AD), to coincide with the 10th anniversary of Atopica.
As part of the campaign, the company is inviting veterinary surgeons to take part in an online survey for the chance to win an iPad mini: www.surveymonkey.com/s/atopica
In addition, Novartis says it will be offering all sorts of new educational materials for both vets and owners, including research into current trends and attitudes towards AD, insights from experts in the field, and case studies.
Ricardo Garvao, Category Manager for Atopica said: "This year marks an important milestone for the Atopica brand that wouldn't have been possible without the backing of so many vets. Continued investment by Novartis Animal Health into research and education seems a fitting way to extend thanks for this support and so forms one of the key elements of the 'Decade of Comfort' campaign. I am constantly amazed at just how dedicated and hard-working vets are and am immensely proud that Novartis Animal Health shares their goal to help pets remain happy and healthy."
Vetsonic has taken over the marketing of Cavalesse, the oral nutritional supplement for horses that are prone to skin allergies, such as sweet itch.
Cavalesse contains a formulation of water-soluble vitamins and minerals, administered daily via a special pipette, either by sprinkling over a small handful of feed or adding to a treat. Vetsonic claims the supplement helps horses maintain a healthy skin and promotes normal immune function.
Ray Rochester, Managing Director of Vetsonic said: "It's an exciting phase in the development of Vetsonic which will see us rapidly expanding in the increasingly competitive small animal and equine market. Cavalesse is a welcome addition to our portfolio."
For further information, contact Vetsonic customer services on 01653 695333.
Zoetis has launched PetDialog and HorseDialog, the only treatment reminder apps for pet and horse owners which veterinary practices can customise with their own branding.
The app is downloadable from the Apple and Android app stores, but is only accessible by inputting a unique practice identity code.
Once the app is unlocked, owners can then input details of any medications their pet is taking and the date its healthcheck / vaccinations are due, after which they'll receive a practice-branded email reminder.
It's a similar idea to Bayer's reminder app released earlier this year, but with the very clever addition of practice branding.
John Toole, Product Manager at Zoetis said: "This is absolutely the right time to launch this app. Smartphone ownership has rapidly increased from 38% to 60% in the last three years and by 2015 it is predicted that 73% of the UK population will own a Smartphone. The use of Smartphones is no longer just the domain of the young - use and ownership is pretty evenly spread among age groups between 24 and 64, with greatest growth among the 44 -74 age group over the past three years. It comes as no surprise that recent market research confirms 57% of UK pet owners own an Android or iOS device.
"Health businesses are the most trusted by UK mobile users when it comes to receiving mobile messages. More than 11 million consumers have opted in to receive mobile messages from health companies, particularly to take advantage of appointment reminders. This form of communication can really boost loyalty where vet practices are concerned, as 74% of users say that mobile messages that had a use or benefit would maintain or enhance their loyalty to that brand.
"PetDialog has been a significant investment for us and with the help of our customers we plan to re-invest in a robust development stream to ensure the app becomes a valuable tool for pet owners and practices alike. To help practices launch and market the app we've developed an extensive bespoke range of marketing support materials from web pages and email templates to practice posters that come alive in the waiting room with augmented reality."
VetSurgeon gave the app a very quick trial. We found registration simple and easy. Clear navigation. Very good first impression.
Except ...
Honestly, whose idea was it that even the most pathologically insane pet owner would possibly, even once in a million years, want to record (and chart) the amount of time they spend hugging their pet. And not just that, but also to categorise their pet-hugging activities according to whether it was 'Morning Cuddles', 'Afternoon Hugs' or 'Evening Snuggles'. Someone at Zoetis' digital agency must have been smoking something very strong when they came up with that one.
Similarly, the ability to record the amount of time spent playing with the dog, breaking it down into specific activities such as: 'Fetch', Tug of War', 'General Playing', is surely targeted at the 0.0000000001% of the pet owning population that really should be getting some sort of professional help.
That said, the overall idea and execution is top notch. Provided Zoetis removes the madder elements of the app at the next upgrade, it'll get 5 stars out of 5. Meantime, it's still highly recommended.
For more information about the app, contact your Zoetis Account Manager
Sogeval has launched Efex, a marbofloxacin tablet designed for veterinary use.
Efex tablets are available in three blister pack sizes of 10mg, 40mg and 100mg that break into halves for cats and halves and quarters for dogs, facilitating accurate dosing for a wide range of patients.
In cats, the flavoured chewable 10 mg tablets allow accurate dosing of 2.5kg and 5kg cats at 2mg/kg once daily. In dogs the 40mg four way break tablet is designed for a 20 kg dog and the 100mg for a 50kg dog.
Efex tablets are chewable and sogeval says that in a palatability study 7 out of 10 cats readily consumed them.
Each tablet contains a broad-spectrum fluoroquinolone antibiotic marbofloxacin for oral administration, which is readily absorbed reaching maximal plasma concentrations within two hours. It exhibits a wide range of activity against gram-negative and gram-positive bacteria, including Pseudomonas spp and Mycoplasma spp.
Purina has launched a range of services and support materials to help veterinary professionals approach the subject of nutrition with owners.
The Gastrointestinal Support Pack includes a GI handbook, "lunch and learn" educational sessions, a diagnostic support tool (available at www.purinavets.eu/giapplication) and a toolkit containing information sheets and diagnostic advice.
The company has also announced the result of some consumer research it conducted through One Poll in 2013, which revealed that 77% of dogs have experienced some form of digestive health issue, but only 20% of owners had visited their vet to discuss it. The research also found that 80% of owners would be willing to change their pet's diet if it would improve their digestion.
Esther Rawlinson, Purina UK Veterinary Affairs Manager said: "GI upsets and associated 'accidents' can be really distressing for both owner and pet but are seemingly suffered as 'just one of those things' by many. This needn't be the case though, as a lot of GI-related conditions could be prevented or at least managed by the correct nutritional advice and a specially formulated veterinary diet. By addressing nutrition at every consultation, vets can better identify those patients who suffer regular GI disturbance but whose owners do not feel it worthy of mentioning when in the clinic. The survey results show that there is a huge opportunity for vets to improve the health of many more of their clients' dogs and this is why Purina has introduced a range of GI services and support materials. We aim to help vets to include a nutritional assessment in all of their consultations."
For more information call PURINA PetCare Team on 0800 212 161.
The Veterinary Benevolent Fund has launched a new campaign to get a sticker displaying the organisation's helpline telephone number for veterinary professionals in every practice.
The charity has produced a video which explains why.
http://vimeo.com/80551830
Do you have a VBF sticker displayed in your practice? If not, you can order one today. Visit www.vetlife.org.uk
The Kennel Club has announced that it now recognises the Portuguese Pointer, bringing the total number of recognised pedigree breeds in the UK to 212.
The Portuguese Pointer is only the second new breed to be recognised by the Kennel Club in the last five years.
However, as exotic dog breeds have risen in popularity, the Kennel Club reports that many native breeds have fallen out of favour and have been put on its list of 'vulnerable native breeds'; those with less than 300 annual puppy registrations which could disappear from our streets and parks if their numbers continue to decline.
New statistics released by the Kennel Club have shown that whilst vulnerable native breeds have increased in number this year, certain breeds such as the Sealyham Terrier and Otterhound continue to decline. Recent years have seen the Old English Sheepdog and English Setter enter the 'at watch' list. Furthermore, with just 239 Pembroke Corgi registrations so far this year, it is feared the Queen's favourite breed could also become vulnerable for the first time.
By contrast, exotic breeds such as the French Bulldog and Smooth Coated Chihuahua (originally from Mexico) are increasing in popularity with 4,843 and 2,931 registrations respectively so far this year. Between 2003 and 2012 the breeds have increased by 1,232% and 700% respectively.
When the first ever Kennel Club stud book was produced in 1874, just 43 breeds were listed, including many native breeds that are now considered to be vulnerable, such as the Dandie Dinmont Terrier, Clumber Spaniel, Otterhound and Skye Terrier.
Some native breeds continue to thrive, including the English Springer Spaniel, the Cocker Spaniel, the Staffordshire Bull Terrier, the Bulldog, the Golden Retriever, and the Border Terrier, all top ten breeds. But others in the top ten are from abroad.
Visitors to Discover Dogs, which is taking place at Earls Court on November 9th and 10th will be able to meet more than 200 breeds of dog under one roof, including the vulnerable breeds and the latest pedigree dog breeds in the UK.
The newly added Turkish Kangal Dog will also be coming to the event. This breed was added earlier this year and was the first new breed to join the Kennel Club register in almost five years. The Greater Swiss Mountain Dog, officially recognised from 1 October 2008, was the last dog recognised by the Kennel Club prior to the two new additions for this year. Organiser of the Kennel Club's Discover Dogs event, Vanessa McAlpine, said: "The UK is lucky to have so many wonderful dog breeds, and at our Discover Dogs event people have a unique opportunity to meet more than 200 of them, including those that might never cross your path in day to day life because they are so rare, those that are new to our shores and those that have been working with people in Britain for hundreds of years."
To find out more about Discover Dogs, visit www.discoverdogs.org.uk/.
Vétoquinol has launched Flexadin, a new range of joint support products for cats and dogs with osteoarthritis (OA)
Robert Simpson, Flexadin Product Manager said: "This new range is made up of two products: Flexadin Plus and Flexadin Advanced, both are dietetic complementary feeds which are members of a small group of joint support products which contain Omega-3 fatty acids and Vitamin E. These ingredients are proven to aid the support of the metabolism of joints in the case of OA. Although many different joint support aids are available, not all of them contain these extra ingredients."
Vétoquinol says that in addition to Omega-3 fatty acids and Vitamin E, Flexadin Plus contains the traditional ingredients: glucosamine, chondroitin and devil's claw. Flexadin Advanced contains the novel ingredient, UCII - a type of undenatured type II collagen which has been manufactured using a patented process.
Flexadin Plus comes in two formulations, the first is specifically designed for cats/small dogs and the other is for medium/large dogs. Flexadin Advanced is specifically for dogs.
Robert added: "Flexadin Advanced has a specific property which means that the administration rate is only one chew per day whatever the weight of the dog. This has an important impact on the price per day for medium and large dogs which may require more than one tablet of traditional joint support products. This property also makes Flexadin Advanced a convenient option for owners. In addition to this benefit, UCII is becoming more and more popular due to the results of scientific studies in dogs, horses and even humans.
"We are all very excited about the advances this range can bring to veterinary practices."
Both Flexadin Plus and Advanced are presented as palatable, shaped, soft chews which come in zip-lock packs to keep the soft chews fresh and tasty. Flexadin Plus comes in packs of 90 chews whilst Flexadin Advanced comes in packs of 30 chews.
For further information about Flexadin, contact Vétoquinol on: 01280 825424.
Bimeda has launched Recocam, a 20mg/ml meloxicam preparation licensed for use as a single injection course in cattle, horses and pigs.
Bimeda's Head of Technical Services, Padraig Hyland MVB said: "Meloxicam's anti-inflammatory credentials and safety profile is well proven and it remains rightly popular with large animal vets. With our manufacturing expertise it makes sense to add this widely used product to our portfolio. Our aim is to provide a comprehensive range of both established standards and new innovative products for cattle and equine vets, and this is just another step in that process."
Bimeda says Recocam has a broad range of indications including acute respiratory infections, in combination with oral re-hydration in diarrhoea therapy and acute mastitis, for non-infectious locomotor disorders and lameness in pigs and alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders and pain relief associated with equine colic. In cattle Recocam can be given by single subcutaneous or intravenous injection.